Sarepta Therapeutics Stock Sees Short Interest Fall 16.4%

The most recent short interest data has been released by the NASDAQ for the 09/30/2013 settlement date, which shows a 2,071,948 share decrease in total short interest for Sarepta Therapeutics Inc ( SRPT), to 10,564,630, a decrease of 16.40% since 09/13/2013. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days (at the average volume) it would take to close out all of the open short positions if every share traded represented a short position being closed. Average daily volume for SRPT at the 09/30/2013 settlement increased to 3,389,261, as compared to 905,111 at the 09/13/2013 report. That brought "days to cover" down to 3.12, a 77.67% decrease from the 13.96 days to cover calculated at the previous short interest data release.

START SLIDESHOW:
The 10 Most Shorted Stocks of the Dow »

The below chart shows the historical "days to cover" for SRPT at previous short interest release dates:

Loading+chart++2013+TickerTech.com

A decreased "days to cover" value could indicate that short sellers are no longer expecting the same decline in stock price they once were, or it could also indicate a long bet elsewhere was closed where SRPT had been shorted as a hedge.

The chart below shows the one year performance of SRPT shares, versus its 200 day moving average. Looking at this chart, SRPT's low point in its 52 week range is $21.21 per share, with $55.61 as the 52 week high point — that compares with a last trade of $46.83.

Sarepta Therapeutics Inc Chart

According to the ETF Finder at ETF Channel, SRPT makes up 2.59% of the SPDR S&P Biotech ETF (XBI) which is lower by about 0.7% on the day Friday.

In afternoon trading Friday, SRPT was down about 0.2% on the day.

null

If you liked this article you might like

Sound Familiar? Dovish Fed Talk Induces Stock Reversal

Sound Familiar? Dovish Fed Talk Induces Stock Reversal

With an Eye on Biotech, Here's Today's Trading Thesis

With an Eye on Biotech, Here's Today's Trading Thesis

Focused on Two Sectors

Focused on Two Sectors

Solid Biosciences Soars 41% in IPO Despite Late Disclosure of FDA Letter

Solid Biosciences Soars 41% in IPO Despite Late Disclosure of FDA Letter

In This Booming Stock Market, Think Like a Programmer Not a Critic

In This Booming Stock Market, Think Like a Programmer Not a Critic